The revenue declined to Rs. 9056.10 millions for the quarter ended September 2022 as compared to Rs. 9157.70 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 1935.60  millions for the quarter ended September 2022 from Rs. 1875.60 millions of corresponding previous quarter.The company reported a good operating profit of 2790.80 millions compared to 2690.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9056.10 9157.70 -1.11 16350.70 16176.10 1.08 32175.10 29204.70 10.17
Other Income 221.60 150.50 47.24 499.50 467.80 6.78 762.20 1101.90 -30.83
PBIDT 2790.80 2690.50 3.73 4548.00 4325.20 5.15 8320.50 7079.60 17.53
Interest 3.90 3.50 11.43 10.70 11.40 -6.14 19.90 35.30 -43.63
PBDT 2786.90 2687.00 3.72 4537.30 4313.80 5.18 8416.40 5318.30 58.25
Depreciation 163.60 174.30 -6.14 321.80 349.70 -7.98 681.90 786.00 -13.24
PBT 2623.30 2512.70 4.40 4215.50 3964.10 6.34 7734.50 4532.30 70.65
TAX 687.70 637.10 7.94 1123.60 1022.50 9.89 3968.70 1665.40 138.30
Deferred Tax -46.30 -37.80 22.49 -81.00 -72.60 11.57 -105.00 78.70 -233.42
PAT 1935.60 1875.60 3.20 3091.90 2941.60 5.11 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 30.82 29.38 4.89 27.82 26.74 4.03 25.86 24.24 6.68

Glaxosmithkline Phar Share Price

1992.25 -6.90 (-0.35%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.